Plans | Type (1) | Date of grant | Option exerciseprice(in euros) | Optionsoutstandingat January 1, 2021 | Optionscancelled,lapsed or transferred(2)in 2021 | Optionsexercisedin 2021 | Optionsoutstanding at December 31, 2021 | Of which exercisable atDecember 31, 2021 | Exercise deadline | Remaining contractlife(in years) |
---|---|---|---|---|---|---|---|---|---|---|
Lionlead 2 stock options |
Lionlead 2 stock options Type (1)A |
Lionlead 2 stock options Date of grant 04/30/2013 |
Lionlead 2 stock options Option exerciseprice(in euros)52.76 |
Lionlead 2 stock options Optionsoutstandingat January 1, 20211,078,211 |
Lionlead 2 stock options Optionscancelled,lapsed ortransferred (2)in 202140,629 |
Lionlead 2 stock options Optionsexercisedin 2021 (100,285) |
Lionlead 2 stock options Optionsoutstanding at December 31, 20211,018,555 |
Lionlead 2 stock options Of which exercisable atDecember 31, 20211,018,555 |
Lionlead 2 stock options Exercise deadline 04/30/2023 |
Lionlead 2 stock options Remaining contractlife (in years)1.33 |
Total |
TotalType (1)
|
Total Date of grant 1,078,211 |
Total Option exerciseprice(in euros)40,629 |
TotalOptionsoutstanding at January 1, 2021(100,285) |
TotalOptionscancelled,lapsed or transferred (2)in 20211,018,555 |
TotalOptionsexercised in 2021 1,018,555 |
TotalOptions outstanding at December 31, 2021
|
Total Of which exercisable atDecember 31, 2021
|
The vesting period for the above plans has been completed, but the exercise of options remains subject to a continued presence condition until the date of exercise of the options.
2021 | 2020 | |||
---|---|---|---|---|
Number ofoptions | Averageexercise price(in euros) | Number ofoptions | Averageexercise price(in euros) | |
Options at January 1 | 1,078,211 | 52.76 | 1,091,937 | 52.76 |
Options exercised(1) | (100,285) | 52.76 | - | |
Options canceled, lapsed or transferred | 40,629 | 52.76 | (13,726) | 52.76 |
Options outstanding at December 31 | 1,018,555 | 52.76 | 1,078,211 | 52.76 |
Of which exercisable | 1,018,555 | 52.76 | 1,078,211 | 52.76 |
(1) Average share price on exercise (in euros)